Last reviewed · How we verify

Standard Dose Ibuprofen

Ottawa Hospital Research Institute · FDA-approved active Small molecule Under review Quality 0/100

Standard Dose Ibuprofen is a Nonsteroidal anti-inflammatory drug (NSAID) Small molecule drug developed by Ottawa Hospital Research Institute. It is currently FDA-approved for Mild to moderate pain, Fever reduction, Inflammation associated with arthritis and musculoskeletal conditions.

Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.

Standard dose ibuprofen is a small molecule that inhibits the enzyme cyclooxygenase, which is involved in the production of prostaglandins. It is used to manage conditions such as acute post-operative pain, post-operative pain, and possibly other conditions including obesity and post-bariatric surgery pain, as indicated by clinical trials.

At a glance

Generic nameStandard Dose Ibuprofen
SponsorOttawa Hospital Research Institute
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCOX-1, COX-2
ModalitySmall molecule
Therapeutic areaPain Management, Inflammation
PhaseFDA-approved

Mechanism of action

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively blocks COX-1 and COX-2 enzymes, which are responsible for synthesizing prostaglandins—key mediators of inflammation, pain, and fever. By reducing prostaglandin levels in affected tissues, ibuprofen provides analgesic, anti-inflammatory, and antipyretic effects. It is widely used for mild to moderate pain and inflammatory conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Standard Dose Ibuprofen

What is Standard Dose Ibuprofen?

Standard Dose Ibuprofen is a Nonsteroidal anti-inflammatory drug (NSAID) drug developed by Ottawa Hospital Research Institute, indicated for Mild to moderate pain, Fever reduction, Inflammation associated with arthritis and musculoskeletal conditions.

How does Standard Dose Ibuprofen work?

Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.

What is Standard Dose Ibuprofen used for?

Standard Dose Ibuprofen is indicated for Mild to moderate pain, Fever reduction, Inflammation associated with arthritis and musculoskeletal conditions.

Who makes Standard Dose Ibuprofen?

Standard Dose Ibuprofen is developed and marketed by Ottawa Hospital Research Institute (see full Ottawa Hospital Research Institute pipeline at /company/ottawa-hospital-research-institute).

What drug class is Standard Dose Ibuprofen in?

Standard Dose Ibuprofen belongs to the Nonsteroidal anti-inflammatory drug (NSAID) class. See all Nonsteroidal anti-inflammatory drug (NSAID) drugs at /class/nonsteroidal-anti-inflammatory-drug-nsaid.

What development phase is Standard Dose Ibuprofen in?

Standard Dose Ibuprofen is FDA-approved (marketed).

What are the side effects of Standard Dose Ibuprofen?

Common side effects of Standard Dose Ibuprofen include Gastrointestinal upset (nausea, dyspepsia, abdominal pain), Headache, Dizziness, Rash, Gastrointestinal bleeding (with chronic use), Cardiovascular events (with chronic use).

What does Standard Dose Ibuprofen target?

Standard Dose Ibuprofen targets COX-1, COX-2 and is a Nonsteroidal anti-inflammatory drug (NSAID).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing